• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by UL Solutions Inc.

    7/1/26 4:50:34 PM ET
    $ULS
    Precision Instruments
    Health Care
    Get the next $ULS alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001426641
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    UL Solutions Inc.
    SEC File Number
    001-42012
    Address of Issuer
    333 Pfingsten Road
    Northbrook
    ILLINOIS
    60062
    Phone
    847-272-8800
    Name of Person for Whose Account the Securities are To Be Sold
    JENNIFER SCANLON
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director
    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    375003819750.007780811507/01/2026
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common04/01/2025Previously Exercised Stock OptionsIssuerCheckbox not checked3021204/01/2025Cash
    Common05/01/2026Restricted Stock UnitsIssuerCheckbox not checked728805/01/2026N/A

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    10b5-1 Sales for JENNIFER SCANLON11 EAST WALTON STREET
    333 Pfingsten Road
    Northbrook � IL � 60062
    Common06/01/2026125001249982.50
    10b5-1 Sales for JENNIFER SCANLON11 EAST WALTON STREET
    333 Pfingsten Road
    Northbrook � IL � 60062
    Common05/01/2026125001144595.00

    144: Remarks and Signature

    Remarks
    The securities to be sold were acquired upon the previous exercise of stock options during the period of 04/01/2025 through 04/02/2025.
    Date of Notice
    07/01/2026
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    12/09/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Jennifer Scanlon

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $ULS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ULS

    DatePrice TargetRatingAnalyst
    7/14/2026$110.00Neutral → Buy
    UBS
    2/17/2026$86.00Buy
    BofA Securities
    12/17/2025$97.00Neutral → Outperform
    Robert W. Baird
    11/5/2025$84.00Overweight → Neutral
    Analyst
    5/14/2025$71.00Buy → Neutral
    Citigroup
    10/7/2024$60.00Buy
    Citigroup
    7/12/2024$41.00 → $46.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ULS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UL Solutions Sets Date for Second Quarter Results

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the second quarter before the market opens on Tuesday, Aug. 4. Management will host a webcast and conference call that same day at 8:30 a.m. EDT (7:30 a.m. CDT) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions’ website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the conference call will be avai

    7/21/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Warns of Unauthorized UL Marks on Water-Based Fire Extinguishers

    UL Solutions has identified unauthorized UL Certification Marks on Zinshine water-based fire extinguishers The products have not been evaluated by UL Solutions and may pose safety risks UL Solutions recommends that these extinguishers be removed from service immediately UL Solutions (NYSE:ULS), a global leader in applied safety science, issued a public notice regarding Zinshine Water Based Fire Extinguishers, which bear unauthorized UL Certification Marks for the United States and Canada and may pose safety risks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630150077/en/UL Solutions has identified unauthorized UL

    6/30/26 8:24:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Opens Advanced Automotive Electromagnetic Compatibility Laboratory in Japan

    The new Automotive Technology and Innovation Center expands automotive EMC testing in a top global automotive manufacturing hub to support increasingly complex vehicle technologies.   Expands testing in Japan, the world’s third-largest automotive producer, with more than 8 million vehicles manufactured annually Boosts EMC testing for high-voltage, high-current, high-performance next-generation vehicles Strengthens support for automakers and their suppliers in a key global manufacturing hub UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced the opening of a new automotive electromagnetic compatibility laboratory in Toyota City, Japan, expandi

    6/24/26 9:00:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    SEC Filings

    View All

    SEC Form 144 filed by UL Solutions Inc.

    144 - UL Solutions Inc. (0001901440) (Subject)

    7/1/26 4:50:34 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form 144 filed by UL Solutions Inc.

    144 - UL Solutions Inc. (0001901440) (Subject)

    6/9/26 10:36:14 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. filed SEC Form 8-K: Leadership Update

    8-K - UL Solutions Inc. (0001901440) (Filer)

    6/3/26 4:13:28 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Genovesi John A bought $9,366 worth of shares (145 units at $64.59), increasing direct ownership by 0.57% to 31,112 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    5/15/26 4:48:07 PM ET
    $ULS
    Precision Instruments
    Health Care

    Officer Hancock Lynn H bought $623 worth of shares (8 units at $77.82), converted options into 1,293 shares and covered exercise/tax liability with 573 shares, increasing direct ownership by 4% to 21,331 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    5/5/26 5:51:09 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Thaman Michael H

    4 - UL Solutions Inc. (0001901440) (Issuer)

    7/8/26 8:52:56 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form 4 filed by Director Kini Vikram

    4 - UL Solutions Inc. (0001901440) (Issuer)

    7/8/26 8:51:20 PM ET
    $ULS
    Precision Instruments
    Health Care

    President and CEO Scanlon Jennifer F. sold $1,240,277 worth of shares (12,500 units at $99.22) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 164,224 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    7/2/26 8:13:46 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UL Solutions Inc. upgraded by UBS with a new price target

    UBS upgraded UL Solutions Inc. from Neutral to Buy and set a new price target of $110.00

    7/14/26 8:58:35 AM ET
    $ULS
    Precision Instruments
    Health Care

    BofA Securities resumed coverage on UL Solutions Inc. with a new price target

    BofA Securities resumed coverage of UL Solutions Inc. with a rating of Buy and set a new price target of $86.00

    2/17/26 7:29:05 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded UL Solutions Inc. from Neutral to Outperform and set a new price target of $97.00

    12/17/25 8:48:07 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    UL Solutions Breaks Ground on Global Fire Science Center of Excellence in Illinois

    The advanced fire safety testing and R&D facility will be dedicated to identifying, evaluating and mitigating fire risks. UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory investments to date, helping to reduce fire risks globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826231103/en/UL Solutions has announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory i

    8/26/25 5:30:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Names New Chief Legal Officer

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

    3/11/25 9:15:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Financials

    Live finance-specific insights

    View All

    UL Solutions Sets Date for Second Quarter Results

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the second quarter before the market opens on Tuesday, Aug. 4. Management will host a webcast and conference call that same day at 8:30 a.m. EDT (7:30 a.m. CDT) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions’ website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the conference call will be avai

    7/21/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Announces Quarterly Dividend

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.145 per share. The dividend will be paid on June 8 to shareholders of record as of the close of business on May 29. About UL Solutions A global leader in applied safety science, UL Solutions Inc. (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, advisory offerings and software solutions that support our customers' product innovation and business growth. The UL Mark serves as a recogn

    5/20/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Reports Strong First Quarter 2026 Results

    First Quarter 20261 Strong revenue growth of 7.5% to $758 million, including 5.7% organic revenue growth Net income of $97 million increased 36.6%, Adjusted Net Income of $107 million increased 33.8%. Net income margin of 12.8% increased 270 basis points Diluted earnings per share of $0.45 increased 36.4%, Adjusted Diluted Earnings Per Share of $0.50 increased 35.1% Adjusted EBITDA of $197 million increased 22.4%, Adjusted EBITDA margin of 26.0% expanded 320 basis points Active portfolio management to enhance strategic focus and fund growth Strengthens full-year Adjusted EBITDA margin outlook UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today

    5/5/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/13/24 12:26:41 PM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 5:49:12 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form SC 13G filed by UL Solutions Inc.

    SC 13G - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 10:34:15 AM ET
    $ULS
    Precision Instruments
    Health Care